مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.
Normal view MARC view ISBD view

Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. [electronic resource]

By:
  • Laros-van Gorkom, B A P
Contributor(s):
  • Huisman, C A M
  • Wijermans, P W
  • Schipperus, M R
Producer: 20080108Description: 333-8 p. digitalISSN:
  • 0300-2977
Subject(s):
  • Alemtuzumab
  • Antibodies, Monoclonal -- administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm -- administration & dosage
  • Antigens, CD -- drug effects
  • Antigens, Neoplasm -- drug effects
  • Aspergillosis -- chemically induced
  • CD52 Antigen
  • Drug Evaluation
  • Drug Resistance, Neoplasm
  • Glycoproteins -- drug effects
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
  • Medical Records
  • Netherlands
  • Opportunistic Infections -- chemically induced
  • Pneumonia, Pneumocystis -- chemically induced
  • Remission Induction
  • Retrospective Studies
  • Surveys and Questionnaires
  • Treatment Outcome
  • Vidarabine -- analogs & derivatives
In: The Netherlands journal of medicine vol. 65
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Evaluation Study; Journal Article

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 1 Real-time quantitative PCR assay for analysis of platelet glycoprotein IIIa gene expression.
    by Ficko, Tanja
  • 2 Evaluation of multiple myeloma cell apoptosis in primary bone marrow samples.
    by Rebersek, Katarina
  • 3 Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
    by Zver, Samo
  • 4 Cyclosporin A as an immunosuppressive treatment modality for patients with refractory autoimmune thrombocytopenic purpura after splenectomy failure.
    by Zver, Samo
  • 5 Reticulocyte analysis using light microscopy and two different flow cytometric procedures.
    by Preložnik-Zupan, Irena
  • 6 Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3.
    by Šlejkovec, Zdenka
  • 7 Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation.
    by Zver, Samo
  • 8 Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
    by Skerget, Matevz
  • 9 Selective apoptosis of multiple myeloma cells in primary samples induced by arsenic trioxide.
    by Reberšek, Katarina
  • 10 Increased red cell distribution width is associated with poor stem cell mobilization in patients with advanced chronic heart failure.
    by Poglajen, Gregor
  • 11 Cardiac granulocytic sarcoma diagnosed by intracardiac echocardiography-guided biopsy.
    by Koželj, Mirta
  • 12 Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia.
    by Podgornik, Helena
  • 13 Rare manifestation of the thrombotic microangiopathy in a patient with sarcoidosis, common variable immunodeficiency and large B-cell non-hodgkin lymphoma: case report.
    by Ekart, Robert
  • 14 Splenectomy for severe autoimmune cytopenias after allogenic stem cell transplantation: case report.
    by Proleznik, Irena
  • 15 Glutamate dehydrogenase activity in lymphocytes of B-cell chronic lymphocytic leukaemia patients.
    by Pajic, Tadej
  • 16 Utility of in vitro closure time test for evaluating platelet-related primary hemostasis in dialysis patients.
    by Zupan, Irena Preloznik
  • 17 Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.
    by Zver, Samo
  • 18 Absorption and elimination of imatinib through the rat intestine in vitro.
    by Kralj, Eva
  • 19 CpG-ODN Stimulation in Population Screening Monoclonal B-Cell Lymphocytosis.
    by Podgornik, Helena
  • 20 RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia.
    by Podgornik, Helena
Close

Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.

APA

Laros-van Gorkom B. A. P., Huisman C. A. M., Wijermans P. W. & Schipperus M. R. (20080108). Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. : The Netherlands journal of medicine.

Chicago

Laros-van Gorkom B A P, Huisman C A M, Wijermans P W and Schipperus M R. 20080108. Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. : The Netherlands journal of medicine.

Harvard

Laros-van Gorkom B. A. P., Huisman C. A. M., Wijermans P. W. and Schipperus M. R. (20080108). Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. : The Netherlands journal of medicine.

MLA

Laros-van Gorkom B A P, Huisman C A M, Wijermans P W and Schipperus M R. Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. : The Netherlands journal of medicine. 20080108.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site